Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

The Food and Drug Administration's (FDA's) new final rule on expanded access to investigational drugs has the potential to result in increasing clinical trials through its advocacy of intermediate-size patient populations.

FDA ruling may increase clinical trials